First Time Loading...

Science 37 Holdings Inc
NASDAQ:SNCE

Watchlist Manager
Science 37 Holdings Inc Logo
Science 37 Holdings Inc
NASDAQ:SNCE
Watchlist
Price: 5.75 USD Market Closed
Updated: Apr 24, 2024

Intrinsic Value

Science 37 Holdings, Inc. is an emerging growth company, which provides technology-based solutions that enables decentralized clinical trials. [ Read More ]

The intrinsic value of one SNCE stock under the Base Case scenario is 15.52 USD. Compared to the current market price of 5.75 USD, Science 37 Holdings Inc is Undervalued by 63%.

Key Points:
SNCE Intrinsic Value
Base Case
15.52 USD
Undervaluation 63%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Science 37 Holdings Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling SNCE stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Science 37 Holdings Inc

Provide an overview of the primary business activities
of Science 37 Holdings Inc.

What unique competitive advantages
does Science 37 Holdings Inc hold over its rivals?

What risks and challenges
does Science 37 Holdings Inc face in the near future?

Has there been any significant insider trading activity
in Science 37 Holdings Inc recently?

Summarize the latest earnings call
of Science 37 Holdings Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Science 37 Holdings Inc.

Provide P/S
for Science 37 Holdings Inc.

Provide P/E
for Science 37 Holdings Inc.

Provide P/OCF
for Science 37 Holdings Inc.

Provide P/FCFE
for Science 37 Holdings Inc.

Provide P/B
for Science 37 Holdings Inc.

Provide EV/S
for Science 37 Holdings Inc.

Provide EV/GP
for Science 37 Holdings Inc.

Provide EV/EBITDA
for Science 37 Holdings Inc.

Provide EV/EBIT
for Science 37 Holdings Inc.

Provide EV/OCF
for Science 37 Holdings Inc.

Provide EV/FCFF
for Science 37 Holdings Inc.

Provide EV/IC
for Science 37 Holdings Inc.

Show me price targets
for Science 37 Holdings Inc made by professional analysts.

What are the Revenue projections
for Science 37 Holdings Inc?

How accurate were the past Revenue estimates
for Science 37 Holdings Inc?

What are the Net Income projections
for Science 37 Holdings Inc?

How accurate were the past Net Income estimates
for Science 37 Holdings Inc?

What are the EPS projections
for Science 37 Holdings Inc?

How accurate were the past EPS estimates
for Science 37 Holdings Inc?

What are the EBIT projections
for Science 37 Holdings Inc?

How accurate were the past EBIT estimates
for Science 37 Holdings Inc?

Compare the revenue forecasts
for Science 37 Holdings Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Science 37 Holdings Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Science 37 Holdings Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Science 37 Holdings Inc compared to its peers.

Compare the P/E ratios
of Science 37 Holdings Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Science 37 Holdings Inc with its peers.

Analyze the financial leverage
of Science 37 Holdings Inc compared to its main competitors.

Show all profitability ratios
for Science 37 Holdings Inc.

Provide ROE
for Science 37 Holdings Inc.

Provide ROA
for Science 37 Holdings Inc.

Provide ROIC
for Science 37 Holdings Inc.

Provide ROCE
for Science 37 Holdings Inc.

Provide Gross Margin
for Science 37 Holdings Inc.

Provide Operating Margin
for Science 37 Holdings Inc.

Provide Net Margin
for Science 37 Holdings Inc.

Provide FCF Margin
for Science 37 Holdings Inc.

Show all solvency ratios
for Science 37 Holdings Inc.

Provide D/E Ratio
for Science 37 Holdings Inc.

Provide D/A Ratio
for Science 37 Holdings Inc.

Provide Interest Coverage Ratio
for Science 37 Holdings Inc.

Provide Altman Z-Score Ratio
for Science 37 Holdings Inc.

Provide Quick Ratio
for Science 37 Holdings Inc.

Provide Current Ratio
for Science 37 Holdings Inc.

Provide Cash Ratio
for Science 37 Holdings Inc.

What is the historical Revenue growth
over the last 5 years for Science 37 Holdings Inc?

What is the historical Net Income growth
over the last 5 years for Science 37 Holdings Inc?

What is the current Free Cash Flow
of Science 37 Holdings Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Science 37 Holdings Inc.

Financials

Balance Sheet Decomposition
Science 37 Holdings Inc

Current Assets 75.5m
Cash & Short-Term Investments 56.4m
Receivables 10.6m
Other Current Assets 8.5m
Non-Current Assets 200k
Other Non-Current Assets 200k
Current Liabilities 18.1m
Accounts Payable 6.7m
Accrued Liabilities 8.4m
Other Current Liabilities 3m
Non-Current Liabilities 5.9m
Other Non-Current Liabilities 5.9m
Efficiency

Earnings Waterfall
Science 37 Holdings Inc

Revenue
60.3m USD
Cost of Revenue
-42.3m USD
Gross Profit
17.9m USD
Operating Expenses
-78.1m USD
Operating Income
-60.2m USD
Other Expenses
-64.4m USD
Net Income
-124.7m USD

Free Cash Flow Analysis
Science 37 Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

SNCE Profitability Score
Profitability Due Diligence

Science 37 Holdings Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Negative 1-Year Revenue Growth
Negative Operating Income
20/100
Profitability
Score

Science 37 Holdings Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

SNCE Solvency Score
Solvency Due Diligence

Science 37 Holdings Inc's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
59/100
Solvency
Score

Science 37 Holdings Inc's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SNCE Price Targets Summary
Science 37 Holdings Inc

Wall Street analysts forecast SNCE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SNCE is 13.83 USD .

Lowest
Price Target
Not Available
Average
Price Target
13.83 USD
141% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

SNCE Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

SNCE Price
Science 37 Holdings Inc

1M 1M
-
6M 6M
-18%
1Y 1Y
-16%
3Y 3Y
-97%
5Y 5Y
-97%
10Y 10Y
-97%
Annual Price Range
5.75
52w Low
4.09
52w High
11.762
Price Metrics
Average Annual Return -23.28%
Standard Deviation of Annual Returns 63.78%
Max Drawdown -99%
Shares Statistics
Market Capitalization 34.7m USD
Shares Outstanding 6 028 170
Percentage of Shares Shorted 0.41%

SNCE Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Science 37 Holdings Inc Logo
Science 37 Holdings Inc

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

34.7m USD

Dividend Yield

0%

Description

Science 37 Holdings, Inc. is an emerging growth company, which provides technology-based solutions that enables decentralized clinical trials. The company is headquartered in Culver City, California. The company went IPO on 2020-11-20. The firm develops Decentralized Clinical Trial Operating System (DCT OS), which enable workflow orchestration, evidence generation and data harmonization on a platform. Its platform configures studies and fused with its networks of telemedicine investigators, mobile nurses, remote coordinators, patient communities and connected devices. Its offerings include Fully DTC, Metasite, Technology+, Study Configuration and Diversity & Inclusion. Its technology and virtual capabilities ranging from executing a virtual clinical trial, to supplementing a trial as a virtual site, to enabling clinical trials through technology. The company’s customer base consists of pharmaceutical corporations, biotech companies, and academic and governmental institutions.

Contact

CALIFORNIA
Culver City
600 Corporate Pointe, Suite 320
+19843773737.0
https://lifesciacquisition.com

IPO

2020-11-20

Employees

-

Officers

CEO & Director
Mr. David Coman
Chief Legal & Human Resources Officer and Secretary
Ms. Christine A. Pellizzari J.D.
Chief Delivery Officer
Ms. Darcy Forman
Chief Financial Officer
Mr. Mike Zaranek
VP and Head of Quality Assurance & Compliance
Irena Lambridis
Vice President of Marketing & Communications
Ms. Margie Gimbel Kooman
Show More
Chief Strategy & Marketing Officer
Mr. Drew Bustos
Chief Medical Officer
Mr. Jonathan Cotliar M.D.
Chief Commercial Officer
Mr. Michael Shipton
VP of Corporate Strategy & Chief of Staff
Mr. Tyler Van Horn
Show Less

See Also

Discover More
What is the Intrinsic Value of one SNCE stock?

The intrinsic value of one SNCE stock under the Base Case scenario is 15.52 USD.

Is SNCE stock undervalued or overvalued?

Compared to the current market price of 5.75 USD, Science 37 Holdings Inc is Undervalued by 63%.